Combination of protein tyrosine phosphatase inhibitors and human growth hormone for the treatment of muscle atrophy and related disorders

Details for Australian Patent Application No. 2008328683 (hide)

Owner Novartis AG

Inventors Paul, Angelika Christina; Barnes, David

Agent Davies Collison Cave

Pub. Number AU-A-2008328683

PCT Pub. Number WO2009/068689

Priority 60/991,457 30.11.07 US

Filing date 1 December 2008

Wipo publication date 4 June 2009

International Classifications

A61K 31/433 (2006.01) - Thiadiazoles

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/068689 Priority application(s): WO2009/068689

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008328705-Double-chamber humidifier tube

2008328682-Composition for treatment and prevention of hair loss and premature graying of hair